Cell replication in the arterial wall: Activation of signaling pathway following in vivo injury

Circulation Research

Volumn 82, Issue 6, 1998, Pages 713-721

  Koyama, Hiroyuki ^a   Eric Olson, N ^a   Frank Dastvan, F ^a   Reidy, Michael A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Balloon injury; Cell replication; Extracellular signal regulated kinase 1 2; Mitogen activated protein kinase phosphatese 1; p70 S6 kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL MODEL; ARTERY INJURY; ARTICLE; BALLOON CATHETER; CAROTID ARTERY; CELL DIVISION; ENZYME ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0345596451     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.6.713     Document Type: Article

References (44)

1. Clowes AW, Reidy MA. Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
2. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res. 1991;68:106-113.
3. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A. 1991;88:3739-3743.
4. Lindner V, Olson NE, Clowes AW, Reidy MA. Inhibition of smooth muscle cell proliferation in injured rat arteries: interaction of heparin with basic fibroblast growth factor. J Clin invest. 1992;90:2044-2049.
5. Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, Nabel EG. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci U S A, 1996;93:7905-7910.
6. Xu Q, Liu Y, Gorospe M, Udelsman R, Holbrook NJ. Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest. 1996;97:508-514.
7. Lai K, Wang H, Lee WS, Jain MK, Lee ME, Haber E. Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. J Clin Invest. 1996;98:1560-1567.
8. Chen D, Krasinski K, Chen D, Sylvester A. Chen J, Nisen PD, Andrés V. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. J Clin Invest. 1997;99:2334-2341.
9. Xu Q, Faweett TW, Gorospe M, Guyton KZ, Liu Y, Holbrook NJ. Induction of mitogen-activated protein kinase phophatase-1 during acute hypertension. Hypertension. 1997;30:106-111.
10. Pelech SL, Sanghera JS. MAP kinases: charting the regulatory pathways. Science. 1992;257:1355-1356.
11. Seger R, Krebs EG. The MAPK signaling cascade. FASKB J. 1995;9:726-735. 726-735.
12. Cano E, Mahadevan LC. Parallel signal processing among mammalian MAPKs. Trends Biochem Sci. 1995;20:117-122.
13. Lubinus M, Meier KE, Smith EA, Gause KC, LeRoy EC, Trojanowska M. Independent effects of platelet-derived growth factor isoforms on mitogen-activated protein kinase activation and mitogenesis in human dermal fibroblasts. J Biol Chem. 1994;269:9822-9825.
14. Ahn NG, Seger R, Bratlien RL, Diltz CD, Tonks NK, Krebs EG. Multiple components in an epidermal growth factor-stimulated protein kinase cascade: in vitro activation of a myelin basic protein/microtubule-associated protein 2 kinase. J Biol Chem. 1991;266:4220-4227.
15. Gómez N, Cohen P. Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature. 1991;353:170-173.
16. Campbell JS, Wenderoth MP, Hauschka SD, Krebs EG. Differential activation of mitogen-activated protein kinase in response to basic fihroblast growth factor in skeletal muscle cells. Proc Natl Acad Sci U S A. 1995;92:870-874.
17. mapk are required tor fibroblast proliferation. Proc Natl Acad Sci U S A. 1993;90:8319-8323.
18. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activatcd protein kinase cascade. Proc Natl Acad Sci U S A. 1995;92:7686-7689.
19. Sun H, Charles CH, Lau LF, Tonks NK. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell. 1993;75:487-493.
20. Noguchi T, Metz R, Chen L, Mattéi MG, Carrasco D, Bravo R. Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth. Mol Cell Biol. 1993;13:5105-5205.
21. Brondello JM, McKenzie FR, Sun H, Tonks NK, Pouysségur J. Consti tutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts. Oncogene. 1995;10:1895-1904.
22. Zhao Z, Tan Z, Diltz CD, You M, Fischer EH. Activation of mitogenactivated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases. J Biol Chem. 1996;271:22251-22255.
23. Yan M, Dai T, Deak JC, Kyriakis JM, Zon LI, Woodgett JR, Templeton DJ. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1, Nature. 1994;372:798-800.
24. Force T, Pombo CM, Avruch JA, Bonventre JV, Kyriakis JM. Stress-activated protein kinases in cardiovascular disease. Circ Res. 1996;78:947-953.
25. Bokemeyer D, Sorokin A, Yan M, Ahn NG, Templeton DJ, Dunn MJ. Induction of mitogen-activated protein kinase phosphatase 1 by the stress-activated protein kinase signaling pathway but not by extracellular signal-regulated kinase in fibroblasts. J Biol Chem. 1996;271:639-642.
26. Scott PH, Belham CM, al-Hafidh J, Chilvers ER, Peacock AJ, Gould GW, Plevin R. A regulatory role for cAMP in phosphatidylinositol 3-kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-growth-factor-stimulatcd bovine airway smooth-muscle cells. Biochem J. 1996;318:965-971.
27. Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell. 1996;87:1069-1078.
28. s6k function is essential for G1 progression. Nature. 1993;363:170-172.
29. cdc2 kinase activation in T lymphocytes. J Biol Chem. 1993;268:22737-22745.
30. Albers MW, Williams RT, Brown EJ, Tanaka A, Hall FL, Schreiber SL. FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line. J Biol Chem. 1993;268:22825-22829.
31. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature. 1994;372:570-573.
32. Ballou LM, Luther H, Thomas G. MAP2 kinase and 70K S6 kinase lie on distinct signalling pathways, Nature. 1991;349:348-350.
33. Duff JL, Monia BP, Berk BC. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells: effect of actinomycin D and antisense oligonucleotides. J Biol Chem. 1995;270:7161-7166.
34. Koyama H, Reidy MA. Reinjury of arterial lesions induces intima; smooth muscle cell replication that is not controlled by fibroblast growth factor 2. Cric Res. 1997;80:408-417.
35. Alessi DR. Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem. 1995;270:27489-27494.
36. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
37. Majesky MW, Benditt EP, Schwartz SM. Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. Proc Natl Acad Sci U S A. 1988;85:1524-1528.
38. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 1993;7:2135-2148.
39. 1-adrenergic receptor-stimulated cardiac myoeyte hypertrophy but not activation of hypertrophy- associated genes: evidence for involvement of p70 S6 kinase. Circ Res. 1997;81:176-186.
40. Oison NE, Chao S, Lindner V, Reidy MA. Intimal smooth muscle cell proliferation after balloon catheter injury: the role of basic fibroblast growth factor. Am J Pathol. 1992;140:1017-1023.
41. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991;68:450-456.
42. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest. 1992;89:507-511.
43. Fingerle J, Au YP, Clowes AW, Reidy MA. Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis. 1990;10:1082-1087.
44. MAPK cascade. J Biol Chem. 1997;272:1368-1376.